Corneal cross-linking

Corneal cross-linking (CXL) is a medical procedure aimed at strengthening the cornea if it has been weakened by conditions such as keratoconus or corneal ectasia. The procedure involves the use of ultraviolet (UV) light and riboflavin (vitamin B2) drops to promote the formation of bonds between collagen fibers in the cornea, thereby increasing its strength and stability.

Overview

The cornea is the transparent front part of the eye that covers the iris, pupil, and anterior chamber. Conditions like keratoconus cause the cornea to thin and bulge outward, leading to distorted vision. Corneal cross-linking seeks to halt the progression of this bulging and prevent further deterioration of vision by enhancing the corneal structure.

Procedure

Corneal cross-linking can be performed using two different methods: the epithelium-off (Epi-Off) and the epithelium-on (Epi-On) techniques.

Epi-Off Technique

In the Epi-Off technique, the outer layer of the cornea (the epithelium) is removed to allow for better penetration of the riboflavin into the deeper layers of the cornea. After the removal, riboflavin drops are applied to the cornea, which is then exposed to UV light for a period of time. This exposure causes the riboflavin to react with the collagen fibers, leading to the formation of additional cross-links that strengthen the cornea.

Epi-On Technique

The Epi-On technique, also known as transepithelial CXL, does not involve the removal of the epithelium. Instead, modifications are made to the riboflavin solution to enhance its penetration through the epithelial layer. This method is less invasive and may reduce the risk of postoperative complications and discomfort, but it is debated whether it is as effective as the Epi-Off technique.

Indications

Corneal cross-linking is primarily indicated for patients with progressive keratoconus or corneal ectasia post-laser eye surgery. It may also be considered for patients with certain corneal infections or thinning disorders, as a preventive measure to avoid further deterioration.

Risks and Complications

While corneal cross-linking is generally safe, it does carry risks and potential complications, including: - Infection - Corneal haze - Delayed epithelial healing - Changes in corneal shape leading to vision changes - Rarely, corneal scarring or the need for corneal transplantation

Outcomes

Studies have shown that corneal cross-linking can effectively halt the progression of keratoconus and corneal ectasia in a significant number of patients. Some patients may experience an improvement in vision, although the primary goal is to prevent further deterioration.

Conclusion

Corneal cross-linking represents a significant advancement in the treatment of corneal thinning disorders. By strengthening the cornea, CXL can halt the progression of diseases like keratoconus, potentially preventing the need for corneal transplantation and preserving vision.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian